Evidence map›Paper›PMID 40494952›Full record

ArticleOncogene2025

HPV status impacts oncobacteria abundance and prognostic relevance in head and neck squamous cell carcinoma.

Travis D Kerr, Natalie L Silver, Radhika Duggal, Jin Dai, Hannah Simmons, Subha Singh, Akeesha A Shah, Kristianna M Fredenburg, Apollo R Stacy, Daniel J McGrail

Abstract read
In one paragraph

Article in Oncogene, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. [Application of neoadjuvant immunotherapy in head and neck squamous cell carcinoma: From mechanisms to clinical practice].Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Travis D Kerr *Center for Immunotherapy and Precision Immuno-Oncology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.ORCID http://orcid.org/0000-0001-5460-860X
Natalie L Silver *Center for Immunotherapy and Precision Immuno-Oncology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.
Radhika DuggalCenter for Immunotherapy and Precision Immuno-Oncology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.ORCID http://orcid.org/0000-0002-3368-5822
Jin DaiCenter for Immunotherapy and Precision Immuno-Oncology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.
Hannah SimmonsCenter for Immunotherapy and Precision Immuno-Oncology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.
Subha SinghCenter for Immunotherapy and Precision Immuno-Oncology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.
Akeesha A ShahDepartment of Pathology and Laboratory Medicine, Cleveland Clinic, Cleveland, OH, USA.
Kristianna M FredenburgDepartment of Pathology, University of Florida College of Medicine, Gainesville, FL, USA.
Apollo R StacyDepartment of Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.
Daniel J McGrailCenter for Immunotherapy and Precision Immuno-Oncology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA. mcgraid@ccf.org.ORCID http://orcid.org/0000-0002-6669-6069

Funding

Role of sulfide in oral microbiota-host interactions that promote periodontitisR00DE031372 · NIDCR · CLEVELAND CLINIC LERNER COM-CWRU · PI STACY, APOLLO · 2023 to 2025
$908k
Remodeling host immunity in oral cancer with personalized RNA nanoparticle vaccinesK08DE029503 · NIDCR · UNIVERSITY OF FLORIDA · PI SILVER, NATALIE LEA · 2020 to 2024
$777k
Determining the Immunological Consequences of DNA Replication Stress Response Defects in Renal Cells Carcinoma to Improve Immunotherapy OutcomesR00CA240689 · NCI · CLEVELAND CLINIC LERNER COM-CWRU · PI MCGRAIL, DANIEL JAMES · 2022 to 2024
$747k
NCI NIH HHS R00 CA240689NIDCR NIH HHS K08 DE029503NIDCR NIH HHS R00 DE031372U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) R00CA240689U.S. Department of Health & Human Services | NIH | National Institute of Dental and Craniofacial Research (NIDCR) K08DE029503
6 · The paper itself

Abstract

The intratumoral microbiome is emerging as an intrinsic microenvironment feature of some cancers, most notably those along the digestive tract. Opportunistic pathogenic bacteria, such as Fusobacterium nucleatum, can enrich within certain tumors, ultimately leading to alterations in the tumor microenvironment. However, why some tumors have a higher abundance of tumor-associated bacteria, or oncobacteria, than others remains unknown. To address this question, we quantified the presence of oncobacteria in head and neck squamous cell carcinomas (HNSCCs). We found that accumulation of oncobacteria was independent of tumor stage and size, as well as patient characteristics. In contrast, we discovered that human papillomavirus (HPV)-negative tumors exhibited significantly higher accumulation of oncobacteria than HPV+ tumors. Furthermore, the abundance of oncobacteria was associated with worse overall survival in HPV+ tumors. These findings were validated in an independent cohort. Subsequent analysis of Epstein-Barr virus (EBV)+ gastric cancer suggests this phenomenon generalizes to other virally mediated cancers. Co-culture studies of HNSCC cell lines with Fusobacterium nucleatum demonstrated that HPV-negative cells have enhanced proliferation in the presence of Fusobacterium nucleatum compared to HPV+ cells, suggestive of tumor cell intrinsic determinants of oncobacteria accumulation. Together, these results illuminate tumor features that contribute to the accumulation of oncobacteria.

Indexed as

Head and Neck NeoplasmsPapillomaviridaePapillomavirus InfectionsSquamous Cell Carcinoma of Head and NeckAgedCell Line, TumorFemaleFusobacterium nucleatumHumansMaleMicrobiotaMiddle AgedPrognosisTumor Microenvironment

Identifiers

PMID40494952
PMCPMC12183080

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.